BIOMAT Database Logo BIOMAT Database Logo

[Experimental therapy of acute kidney failure with prostenon, a Soviet prostaglandin E2]. 1983

R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ

It has been shown in experimental acute renal failure that intraarterial and intravenous injection of prostaglandin E2 (prostenon) recovers glomerular filtration and tubular reabsoption, i. e. completely eliminates acute renal failure.

UI MeSH Term Description Entries
D007269 Injections, Intra-Arterial Delivery of drugs into an artery. Injections, Intraarterial,Intra-Arterial Injections,Intraarterial Injections,Injection, Intra-Arterial,Injection, Intraarterial,Injections, Intra Arterial,Intra Arterial Injections,Intra-Arterial Injection,Intraarterial Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011459 Prostaglandins E, Synthetic Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE. PGE Synthetic,Prostaglandin E Analogs,Prostaglandin E Analogues,Synthetic Prostaglandins E,Analogs, Prostaglandin E,Analogues, Prostaglandin E,Synthetic, PGE
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
[Morphologic criteria of the efficacy of experimental therapy of acute renal failure with prostaglandin E2].
February 1986, Gematologiia i transfuziologiia,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
[The use of prostaglandin E2 (prostenon) in broncho-obstructive syndrome of patients with pulmonary tuberculosis].
November 1991, Klinicheskaia meditsina,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
Experimental studies on some effects of prostaglandin E2 in acute renal failure.
January 1990, Journal of the Indian Medical Association,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
Prostaglandin E2 and I2 treatment of acute experimental pancreatitis in rats.
January 1986, Pancreas,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
[Correction of metabolic disorders in acute kidney failure caused by hemotransfusion, by intra-aorta administration of prostaglandin E2].
April 1988, Gematologiia i transfuziologiia,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
Acute myocardial infarction associated with prostaglandin E2.
August 1991, American journal of obstetrics and gynecology,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
Decreased renal prostaglandin E2 metabolism: a mechanism for the regulation of prostaglandin activity in acute renal failure.
January 1983, Advances in prostaglandin, thromboxane, and leukotriene research,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
[Use of prostaglandin E2 in the complex treatment of acute renal failure].
May 1990, Gematologiia i transfuziologiia,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
[Experimental models of acute kidney failure].
September 1995, La Revue du praticien,
R M Glants, and B V Kachorovskiĭ, and V L Turchin, and I O Kushch, and L V Kotsaĭ
[Therapy of acute kidney failure].
April 1981, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!